DK0843732T3 - Sekvens af naturlige eller syntetiske retroelementer, der muliggör indsætning af nukleotidsekvenser i en eukaryot celle - Google Patents

Sekvens af naturlige eller syntetiske retroelementer, der muliggör indsætning af nukleotidsekvenser i en eukaryot celle

Info

Publication number
DK0843732T3
DK0843732T3 DK96927085T DK96927085T DK0843732T3 DK 0843732 T3 DK0843732 T3 DK 0843732T3 DK 96927085 T DK96927085 T DK 96927085T DK 96927085 T DK96927085 T DK 96927085T DK 0843732 T3 DK0843732 T3 DK 0843732T3
Authority
DK
Denmark
Prior art keywords
sequence
natural
nucleotide sequences
eukaryotic cell
allowing insertion
Prior art date
Application number
DK96927085T
Other languages
English (en)
Inventor
Andre Choulika
Jean-Francois Nicolas
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0843732T3 publication Critical patent/DK0843732T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK96927085T 1995-08-07 1996-07-25 Sekvens af naturlige eller syntetiske retroelementer, der muliggör indsætning af nukleotidsekvenser i en eukaryot celle DK0843732T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509587A FR2737731B1 (fr) 1995-08-07 1995-08-07 Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote

Publications (1)

Publication Number Publication Date
DK0843732T3 true DK0843732T3 (da) 2007-01-22

Family

ID=9481767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96927085T DK0843732T3 (da) 1995-08-07 1996-07-25 Sekvens af naturlige eller syntetiske retroelementer, der muliggör indsætning af nukleotidsekvenser i en eukaryot celle

Country Status (12)

Country Link
US (2) US6200800B1 (da)
EP (2) EP0843732B1 (da)
JP (2) JP4173543B2 (da)
AT (2) ATE339511T1 (da)
CA (1) CA2226301C (da)
DE (2) DE69638235D1 (da)
DK (1) DK0843732T3 (da)
ES (1) ES2276407T3 (da)
FR (1) FR2737731B1 (da)
HK (1) HK1105662A1 (da)
PT (1) PT843732E (da)
WO (1) WO1997006271A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737731B1 (fr) * 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote
US6534314B1 (en) 1996-06-14 2003-03-18 Massachusetts Institute Of Technology Methods and compositions for transforming cells
US5928914A (en) * 1996-06-14 1999-07-27 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Methods and compositions for transforming cells
EP1194540A1 (en) * 1999-07-14 2002-04-10 Clontech Laboratories Inc. Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
GB2355459B (en) 1999-11-29 2001-09-26 Isis Innovation A dominant conditional lethal genetic system
US20040231006A1 (en) * 2000-04-12 2004-11-18 Silver Daniel P. Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
EP1274854B1 (en) * 2000-04-12 2009-04-08 Dana-Farber Cancer Institute Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
AU2001263160A1 (en) 2000-05-19 2001-12-03 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution
GB2402675B (en) * 2003-05-12 2008-02-20 Oxitec Ltd Resistance dilution
GB2403475B (en) 2003-07-01 2008-02-06 Oxitec Ltd Stable integrands
GB2404382B (en) * 2003-07-28 2008-01-30 Oxitec Ltd Pest control
EP2392657B1 (en) * 2005-07-05 2013-09-25 The Chemo-Sero-Therapeutic Research Institute Modified transposon vector and its use
GB2443186A (en) 2006-10-25 2008-04-30 Oxitec Ltd Expression system for mediating alternative splicing
GB2500113A (en) 2012-03-05 2013-09-11 Oxitec Ltd Arthropod male germline gene expression system
GB201303932D0 (en) 2013-03-05 2013-04-17 Oxitec Ltd Muscle actin promoter
GB2526867A (en) 2014-06-05 2015-12-09 Oxitec Ltd Gene expression system
WO2018029534A1 (en) 2016-08-12 2018-02-15 Oxitec Ltd. A self-limiting, sex-specific gene and methods of using

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0195014A4 (en) 1984-08-06 1988-02-23 Robert Hill LOCKABLE TUBE REEL.
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
EP0300422B1 (en) * 1987-07-21 1992-12-02 The Du Pont Merck Pharmaceutical Company An improved method for preparing stable and viable recombinant animal cell viral vectors
FR2629469B1 (fr) * 1988-03-31 1990-12-21 Pasteur Institut Retrovirus recombinant defectif, son application a l'integration de sequences codantes pour des proteines determinees dans le genome de cultures cellulaires infectables par le retrovirus sauvage correspondant et adns recombinants pour la production de ce retrovirus recombinant
US5658775A (en) * 1988-05-17 1997-08-19 Sloan-Kettering Institute For Cancer Research Double copy retroviral vector
AU656544B2 (en) * 1990-10-31 1995-02-09 Brigham And Women's Hospital Genetic modification of endothelial cells
US5629159A (en) * 1995-06-07 1997-05-13 California Institute Of Technology Immortalization and disimmortalization of cells
FR2737731B1 (fr) * 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote

Also Published As

Publication number Publication date
US6200800B1 (en) 2001-03-13
CA2226301C (fr) 2011-04-19
EP0843732B1 (fr) 2006-09-13
ATE339511T1 (de) 2006-10-15
DE69638235D1 (de) 2010-09-23
HK1105662A1 (en) 2008-02-22
FR2737731A1 (fr) 1997-02-14
EP1760154A3 (fr) 2007-03-14
EP0843732A1 (fr) 1998-05-27
CA2226301A1 (fr) 1997-02-20
WO1997006271A1 (fr) 1997-02-20
FR2737731B1 (fr) 1997-10-10
PT843732E (pt) 2007-01-31
DE69636546T2 (de) 2007-08-02
EP1760154B1 (fr) 2010-08-11
EP1760154A2 (fr) 2007-03-07
JP2008086321A (ja) 2008-04-17
JP4482578B2 (ja) 2010-06-16
JPH11510391A (ja) 1999-09-14
DE69636546D1 (de) 2006-10-26
ES2276407T3 (es) 2007-06-16
ATE477326T1 (de) 2010-08-15
JP4173543B2 (ja) 2008-10-29
US20060269522A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
HK1105662A1 (en) Sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell
ATE321883T1 (de) DE NOVO ODER ßUNIVERSALERß SEQUENZIERUNGS-ARRAY
DK1071804T3 (da) Anvendelse af triplex-struktur-dna-sekvenser til overførsel af nukleotidsekvenser
ATE428809T1 (de) Nukleinsäure-primer und -sonden zur detektion von hiv-1 und hiv-2
ES2173867T3 (es) Uso de nucleotidos externos a la muestra en clonacion genetica.
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
ATE520783T1 (de) Lentivirale vektoren
DK0787191T4 (da) Nukleotidsekvenser af HIV-1 type (eller undertype) O retrovirusantigener
DK634386A (da) Vektorer til ekspression og sekretion af hirudin fra transformeret gaer
FI904494A0 (fi) Diagnos- och amplifieringsfoerfaranden foer eliminering av ett primer-maol-opar i primerns 3'-aenda.
DK0854197T3 (da) Primere til påvisning af HIV-1
RU98100921A (ru) Праймеры для обнаружения вич-1
DE3778096D1 (de) Mittels nitriddispersion verstaerkter stahl.
DE69825269D1 (de) Nachweis von retroviralen untertypen auf der basis der spezifischen sequenzen der hülle
DK0880594T3 (da) Retroviral vektor og dens anvendelse i genterapi
DK0857220T3 (da) Sekvensmodifikation af oligonucleotidprimere til manipulering af ikke-templateret nucleotidaddition
DK631387D0 (da) Virusvektor
Ballaun Charakterisierung der spezifischen Interaktion transregulatorischer Proteine humaner Retroviren (HIV-1, HTL-VI) mit ihren RNA-Zielsequenzen.